NO923114L - Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner - Google Patents

Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner

Info

Publication number
NO923114L
NO923114L NO92923114A NO923114A NO923114L NO 923114 L NO923114 L NO 923114L NO 92923114 A NO92923114 A NO 92923114A NO 923114 A NO923114 A NO 923114A NO 923114 L NO923114 L NO 923114L
Authority
NO
Norway
Prior art keywords
preparation
avgastro
procedures
carboxylic acid
acid esters
Prior art date
Application number
NO92923114A
Other languages
English (en)
Other versions
NO923114D0 (no
Inventor
Mauro Attilio Bertola
Jan Verweij
Henri Gerard Julius Hirs
Original Assignee
Brocades Pharma Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Brocades Pharma Bv filed Critical Brocades Pharma Bv
Publication of NO923114D0 publication Critical patent/NO923114D0/no
Publication of NO923114L publication Critical patent/NO923114L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/02—Preparation
    • C07D477/06—Preparation from compounds already containing the ring or condensed ring systems, e.g. by dehydrogenation of the ring, by introduction, elimination or modification of substituents
    • C07D477/08—Modification of a carboxyl group directly attached in position 2, e.g. esterification
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D499/00—Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO92923114A 1990-12-11 1992-08-10 Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner NO923114L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP90203245 1990-12-11
PCT/NL1991/000261 WO1992010502A1 (en) 1990-12-11 1991-12-11 Heterocyclic carboxylic esters, methods for their preparation and their use for the preparation of gastro-intestinal medicines

Publications (2)

Publication Number Publication Date
NO923114D0 NO923114D0 (no) 1992-08-10
NO923114L true NO923114L (no) 1992-09-28

Family

ID=8205186

Family Applications (1)

Application Number Title Priority Date Filing Date
NO92923114A NO923114L (no) 1990-12-11 1992-08-10 Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner

Country Status (13)

Country Link
EP (1) EP0490450A1 (no)
JP (1) JPH05504151A (no)
KR (1) KR927003604A (no)
AU (1) AU9134791A (no)
CA (1) CA2075812A1 (no)
FI (1) FI923549A0 (no)
HU (2) HU9202596D0 (no)
IE (1) IE914307A1 (no)
IL (1) IL100323A0 (no)
NO (1) NO923114L (no)
PT (1) PT99767A (no)
WO (1) WO1992010502A1 (no)
ZA (1) ZA919764B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9201930D0 (sv) * 1992-06-24 1992-06-24 Astra Ab Gastric antibacterial treatment
EP1483241A4 (en) 2002-03-08 2006-12-13 Bristol Myers Squibb Co CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX6789E (es) * 1980-12-03 1986-07-21 Silanes Lab Procedimiento para la elaboracion de composiciones antibacterianas a base de 1-(2,3'-carboxipropioniloxietil)-2-metil-5-nitroimidazol
DE3372768D1 (de) * 1982-06-03 1987-09-03 Hoffmann La Roche 1-sulfo-2-oxoazetidine derivatives
EP0127274A3 (en) * 1983-03-25 1987-05-20 The Upjohn Company Esters of metronidazole and compositions containing them
DK24089D0 (da) * 1989-01-20 1989-01-20 Hans Bundgaard Novel prodrug derivatives of biologically active agents containing hydroxyl groups or nh-acidic groups

Also Published As

Publication number Publication date
FI923549A (fi) 1992-08-07
EP0490450A1 (en) 1992-06-17
IE914307A1 (en) 1992-06-17
ZA919764B (en) 1992-09-30
NO923114D0 (no) 1992-08-10
JPH05504151A (ja) 1993-07-01
KR927003604A (ko) 1992-12-18
HUT61558A (en) 1993-01-28
WO1992010502A1 (en) 1992-06-25
CA2075812A1 (en) 1992-06-12
PT99767A (pt) 1992-11-30
IL100323A0 (en) 1992-09-06
FI923549A0 (fi) 1992-08-07
HU9202596D0 (en) 1992-10-28
AU9134791A (en) 1992-07-08

Similar Documents

Publication Publication Date Title
NO883974L (no) Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater.
NO883722D0 (no) Fremgangsmaate for fremstilling av antibakterielle kinolon- og naftyridinderivater.
NO904694L (no) Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater.
NO901684L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater.
NO893270D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive tetrahydropyridineddiksyrederivater.
NO883122L (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater.
NO801046L (no) Penem-3-karboksylsyrederivater og fremgangsmaate til fremstilling av samme
NO874850D0 (no) Fremgangsmaate for fremstilling av benzotiadiazinforbindelser og farmasoeytisk akseptable salter derav.
NO172051C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive karboksylsyreesterderivater og deglukoteicoplanin
NO891114L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater.
NO884175D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive heterocykliske derivater.
NO167802C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater.
NO881884D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrrolidin-derivater.
NO923114D0 (no) Heterocykliske karboksylsyreestere, fremgangsmaater for fremstilling av dem og anvendelse av dem for fremstilling avgastro-intestinale medisiner
NO891574D0 (no) Fremgangsmaate for fremstilling av farmasoeytisk anvendbareforbindelser.
NO900972D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater.
NO911892D0 (no) Fremgangsmaate for fremstilling og anvendelse som medikamenter av alfa-oksopyrrol(2,3-b)indoleddiksyrer, estere, amider og beslektede analoger.
NO168825C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-pyrrolidinyltio-1-azabicyklo (3.2.0) hept-2-en-2-karboksylsyrederivater
NO900942D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater.
NO912167L (no) Fremgangsmaate for fremstilling av ftalsyreanhydrid-derivater.
NO882201D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyridinderivater.
NO910740L (no) Fremgangsmaate for fremstilling av estere og alkoholer.
ZA913511B (en) New pharmaceutical use of benzocycloheptathiophene carboxylic acid derivatives
NO880495D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme 1-dethia-2-thia-cefalosporinsyrederivater.
NO890506L (no) Fremgangsmaate for fremstilling av terapeutisk aktive kloranilin-derivater.